Generic Immunosuppressants Have Reduced Costs After Organ Transplantation
American Society of Nephrology (ASN)• Payments by organ transplant recipients and Medicare decreased significantly following the introduction of generic immunosuppressive medications. • Large differences in out-of-pocket payments for immunosuppressive medications between Part D beneficiaries who did and did not qualify for the Medicare low-income subsidy suggest that recipients with resources just above the threshold to qualify for the subsidy may experience considerable financial strain.